Showing results (131-140 of 322) with videos related to
Sort By:
Pageof 33
Protein Engineering|April 1, 1991
Protein engineering of diphtheria-toxin-related interleukin-2 fusion toxins to increase cytotoxic potency for high-affinity IL-2-receptor-bearing target cellsT Kiyokawa, D P Williams, C E Snider, et al.AIDS Research and Human Retroviruses|July 1, 1996
Human immunodeficiency virus type 1 entry into murine cell lines and lymphocytes from transgenic mice expressing a glycoprotein 120-binding mutant mouse CD4K J Wieder, P Chatis, J Boltax, et al.Transplantation Proceedings|December 29, 1998
Immunoglobulin-cytokine fusion molecules: the new generation of immunomodulating agentsY S Kim, W Maslinski, X X Zheng, et al.Transplantation|December 10, 1998
Combined costimulation blockade plus rapamycin but not cyclosporine produces permanent engraftmentY Li, X X Zheng, X C Li, et al.Current Opinion in Immunology|October 1, 1994
Cytokines and the Th1/Th2 paradigm in transplantationP Nickerson, W Steurer, J Steiger, et al.Cytometry|November 1, 1983
Immunofluorescence measurement in a flow cytometer using low-power helium-neon laser excitationH M Shapiro, A N Glazer, L Christenson, et al.Journal of the American Society of Nephrology : JASN|March 1, 1995
The thymic way to transplantation toleranceG Remuzzi, N Perico, C B Carpenter, et al.Transplantation|July 1, 1989
Enhancement of immunosuppression by substitution of fish oil for olive oil as a vehicle for cyclosporineV E Kelley, R L Kirkman, M Bastos, et al.Clinical Immunology and Immunopathology|May 1, 1986
Natural killer cell response to interferonsM Abbud-Filho, B J Ransil, V E Kelley, et al.Annual Review of Medicine|January 1, 1993
Interleukin-2 receptor-directed therapies: antibody-or cytokine-based targeting moleculesT B Strom, V R Kelley, J R Murphy, et al.Pageof 33